Search clinical trials for: Over-expressing Her2-neu

Total 3 results

Novartis Pharmaceuticals

Completed

Lapatinib and Bevacizumab for Metastatic Breast Cancer

Neoplasms, Breast

United States
GlaxoSmithKline

Completed

Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer

Neoplasms, Breast

United States, Australia, Canada, Germany, Argentina, Poland, Russian Federation, Belgium, Spain, Latvia, Netherlands, New Zealand, Mexico, Pakistan, Italy, Austria, Chile, Peru, South Africa, Czech Republic, Hungary, Korea, Republic... and more
Aptium Oncology Research Network
Ortho Biotech Products, L.P.

Unknown

Phase II Study in Patients With Operable Breast Cancer

Breast Cancer

United States

3

Subscribe